Navigation Links
Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
Date:1/24/2013

833)(2,717,038)Cash flows from investing activities:  Proceeds from maturity of held-to-maturity investments

5,000,0003,500,000  Proceeds from maturity of available-for-sale investments

3,200,0009,518,252  Purchases of held-to-maturity investments

(2,500,000)(7,640,000)  Purchases of available-for-sale investments

(4,921,036)(3,046,270)  Purchases of property, plant and equipment

(137,101)(222,826)  Proceeds from sale of property, plant and equipment

7,038-  Purchase of intangible assets

(4,440)(77,738)Net cash provided by investing activities

644,4612,031,418Cash flows from financing activities:  Net proceeds from exercise of options

150,000208,825Net cash provided by financing activities

150,000208,825Effect of exchange rate changes on cash and cash equivalents

(6,313)(26,208)Net increase (decrease) in cash and cash equivalents

156,315(503,003)Cash and cash equivalents at beginning of period

4,653,2266,063,573Cash and cash equivalents at end of period

$4,809,541$5,560,570Cash paid during the period for interest

$12$57Cash paid during the period for income taxes

42,31931,307 

Non-GAAP Financial Measures:  The following table reconciles our operating loss calculated in accordance with accounting principles generally accepted in the U.S. (GAAP) to non-GAAP financial measures that exclude non-cash charges for share-based compensation, and depreciation and amortization expenses from gross profit, operating expenses and operating loss.  The non-GAAP financial measures used by management and disclosed by us are not a substitute for, or superior to, financial measures and consolidated financial results calculated in accordance with GAAP, and you should carefully evaluate our reconciliations to non-GAAP.  We may calculate our non-GAAP financial measures differently
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Uroplasty To Participate In The Oppenheimer 23rd Annual Healthcare Conference
2. Uroplasty To Participate In Two Upcoming Investor Conferences
3. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
4. Uroplasty To Participate In Two Upcoming Conferences
5. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
6. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
7. Uroplasty To Present At The JMP Securities Healthcare Conference
8. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
9. Uroplasty Announces Product Development and New Clinical Trial Initiatives
10. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
11. Cepheid Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "India Pharma Outlook 2015: Accelerating growth to the ... Generics" report to their offering. ... in the 2013 caused by the market,s reaction to ... expected to continue to be healthy, as the momentum ...
(Date:3/5/2015)... N.J. , March 5, 2015  ContraVir Pharmaceuticals, ... focused on the development and commercialization of targeted antiviral ... 27 th Annual ROTH Conference, to be held ... James Sapirstein , Chief ... business during his live presentation and will be available ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vwvddw/therapeutic_drug ) ... report "Therapeutic Drug Monitoring - Technologies, Markets, ... This report deals with therapeutic drug monitoring, ... care by monitoring drug levels in the blood ... improving outcome. TDM is viewed as a component ...
Breaking Medicine Technology:India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3ContraVir to Present at 27th Annual ROTH Conference 2Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2
... , ROME , June ... today a public competition for an award to,recognise an expert ... activities in recent years. The ideal candidate has the,potential to ... outstanding,contributions to medical education in reproductive medicine. The winner,besides receiving ...
... June 28 Breckenridge Pharmaceutical, Inc. ...  The U.S. Food and Drug Administration has granted final approval ... time generic, which is being supplied under a licensing agreement. ... cancer drug marketed by AstraZeneca.  Breckenridge will launch the product ...
Cached Medicine Technology:Serono Symposia International Foundation in Collaboration With ESHRE Announces Public Competition in Reproductive Medicine 2
(Date:3/5/2015)... 05, 2015 At the 7th ... leaders in addiction treatment met today in Jackson, Mississippi ... clinical practices. Among the numerous respected speakers will be ... address the role that pain medications have had in ... treatment options. , "It is hard to believe that ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Califia ... today announced at Natural Products Expo West that its ... now 100 percent soy and dairy free. Califia Farms ... serve bottle and are packed with six grams of ... that includes fiber, B vitamins and magnesium. , Protein ...
(Date:3/5/2015)... Portland, Ore. (PRWEB) March 05, 2015 ... health sciences university founded in 1904, has launched ... behaviors and positive lifestyle changes. The Northwest Center ... educate health professionals, support community outreach, and conduct ... promotion, functional medicine, diet and nutrition. The center ...
(Date:3/5/2015)... Supply & Demand Chain Executive Magazine has ... Know” in the supply chain industry, and we are ... team were included on this year’s list! Russ King ... due to their hard work, their commitment to excellence, ... resolving client needs and challenges. , Russ ...
(Date:3/5/2015)... Dr. Jonathan Glashow a board certified New ... named by Castle Connolly as a Top ... has been selected by Castle Connolly Medical Ltd. for ... care doctors in the tri-state metropolitan New York area ... carefully screens and selects doctors through a rigorous peer ...
Breaking Medicine News(10 mins):Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2
... Company (Nasdaq: WAIN ), announced today that it ... New Markets Tax Credit Leveraged Loan in excess of $7.6 ... Inc.,s Elder Service Program. Harbor Health is one of ... of All inclusive Care for the Elderly (PACE) model which ...
... 20 Here are highlights from the January issue of ... publication as often as you wish. Reprinting is allowed for ... attribution is required. Include the following subscription information ... or call toll-free for subscription information, 800-333-9037, ...
... Corporation,(Nasdaq: VOLC ), a leader in the ... treatment of coronary and peripheral artery,disease, today commented on ... as well as their FFR pressure guide wires following ... Joe Burnett, Vice President of Marketing ...
... HIE and hospital IT pioneer doubles annual revenues, brings ... Carefx Corporation today announced 200 percent revenue growth ... the hospital, health system, integrated delivery network (IDN) and ... increase in client bookings and the addition of some ...
... 3SBio Inc.,(Nasdaq: SSRX ), a leading ... biopharmaceutical products primarily,in China, today announced that it ... Food and Drug Administration (SFDA) for approval of ... thrombocytopenic purpura (ITP) in,China. If the extension ...
... world,s largest and,most advanced video search engine, today ... and Everyday Dish TV. More,fitness and health ... . Leveraging its unique AdHoc platform, blinkx ... and share,resulting advertising revenue with the partners. , ...
Cached Medicine News:Health News:Wainwright Bank Provides $10.6 Million to Harbor Health Services, Inc. 2Health News:January 2009 Mayo Clinic Health Letter Highlights Improved PSA Tests, Dry Eyes and Colds 2Health News:January 2009 Mayo Clinic Health Letter Highlights Improved PSA Tests, Dry Eyes and Colds 3Health News:January 2009 Mayo Clinic Health Letter Highlights Improved PSA Tests, Dry Eyes and Colds 4Health News:Volcano Highlights Commitment, Market Acceptance of FFR Product Line 2Health News:Volcano Highlights Commitment, Market Acceptance of FFR Product Line 3Health News:Volcano Highlights Commitment, Market Acceptance of FFR Product Line 4Health News:Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making 2Health News:Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making 3Health News:3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP 2Health News:3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP 3Health News:3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP 4Health News:blinkx Signs Premiere Fitness Partners to Help Users Find the Perfect Health Regimen and Routine 2Health News:blinkx Signs Premiere Fitness Partners to Help Users Find the Perfect Health Regimen and Routine 3
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products. Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000), BinaxNow E.coli...
... For the qualitative differential ... (P.f) antigen and an antigen ... four species of malaria:plasmodium falciparum ... ovale (P.o) and Plasmodium malariae ...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
Medicine Products: